LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,414.27
+0.35%Forward multiples
Based on analyst estimates
- P/E forward
- 30.48x
- P/E 2026E
- 40.42x
- P/E 2027E
- 28.79x
- P/E 2028E
- 25.10x
- P/S forward
- 13.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 45.78x
- PEG TTM
- 0.92x
- Price / book
- 33.04x
- Price / sales
- 15.39x
- Price / cash flow
- 43.42x
Enterprise value
- Enterprise value
- $1.38T
- EV / sales
- 15.90x
- EV / EBITDA
- 30.73x
- EV / EBIT
- 34.52x
- Market cap
- $1.33T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026